Key Takeaways
- The use of AI-driven systems in decentralized clinical trials can lead to the diffusion of responsibilities across multiple actors and technologies, complicating oversight and accountability.
The use of artificial intelligence (AI)-driven systems in decentralized clinical trials (DCTs) can result in the “diffusion” of responsibilities across...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?